Integrated Hybrid Life Cycle Assessment and Supply Chain Environmental Profile Evaluations of Lead-based (Lead Zirconate Titanate) versus Lead-free (Potassium Sodium Niobate) Piezoelectric Ceramics

The increasing awareness of the environmental and health threats of lead as well as environmental legislation, both in the EU and around the world targeted at decreasing the use of hazardous substances in electrical appliances and products has reinvigorated the race to develop lead-free alternatives to lead zirconate titanate (PZT), which presently dominates the market for piezoelectric materials. Emphasis has been placed on one of the most likely piezoelectric materials, potassium sodium niobate (KNN), as a lead-free replacement for PZT. KNN has been speculated to have better environmental credentials and is considered as a “greener” replacement to PZT. However, a comparative environmental impact assessment of the life cycle phases of KNN versus PZT piezoelectric materials has not been carried out. Such a life cycle assessment is crucial before any valid claims of “greenness” or environmental viability of one material over the other can be made and is the focus of this paper. Against this backdrop, a methodologically robust life cycle supply chain assessment based on integrated hybrid life cycle framework is undertaken within the context of the two piezoelectric materials. Results show that the presence of niobium in KNN constitutes far greater impact across all the 16 categories considered in comparison with PZT. The increased environmental impact of KNN occurs in the early stages of the LCA due to raw material extraction and processing. As a result, the environmental damage has already occurred before its use in piezoelectric applications during which it doesn’t constitute any threat. As such, the use of the term “environmentally friendly” for the description of KNN should be avoided. Cost-benefit analysis of substituting PZT with KNN also indicates that the initial cost of conversion to KNN is greater, especially for energy usage during production. This environmental assessment has allowed us to define and address environmental health and safety as well as sustainability issues that are essential for future development of these materials. Overall, this work demonstrates insightful findings that can be garnered through the application of life cycle assessment and supply chain management to a strategic engineering question which allows industries and policy makers to make informed decisions regarding the environmental consequences of substitute materials, designs, fabrication processes and usage

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes

Background: Mediator complex (MED) proteins have a key role in transcriptional regulation, some interacting with the oestrogen receptor (ER). Interrogation of the METABRIC cohort suggested that MED7 may regulate lymphovascular invasion (LVI). Thus MED7 expression was assessed in large breast cancer (BC) cohorts to determine clinicopathological significance. Methods: MED7 gene expression was investigated in the METABRIC cohort (n = 1980) and externally validated using bc-GenExMiner v4.0. Immunohistochemical expression was assessed in the Nottingham primary BC series (n = 1280). Associations with clinicopathological variables and patient outcome were evaluated. Results: High MED7 mRNA and protein expression was associated with good prognostic factors: low grade, smaller tumour size, good NPI, positive hormone receptor status (p < 0.001), and negative LVI (p = 0.04) status. Higher MED7 protein expression was associated with improved BC-specific survival within the whole cohort and ER+/luminal subgroup. Pooled MED7 gene expression data in the external validation cohort confirmed association with better survival, corroborating with the protein expression. On multivariate analysis, MED7 protein was independently predictive of longer BC-specific survival in the whole cohort and Luminal A subtype (p < 0.001). Conclusions: MED7 is an important prognostic marker in BC, particularly in ER+luminal subtypes, associated with improved survival and warrants future functional analysis

Calpastatin is associated with lymphovascular invasion in breast cancer

Metastasis of breast cancer is a major contributor to mortality. Histological assessment of vascular invasion (VI) provides important prognostic information and demonstrates that VI occurs predominantly via lymphatics in breast cancer. We sought to examine genes and proteins involved in lymphovascular invasion (LVI) to understand the mechanisms of this key disease process. A gene expression array of 91 breast cancer patients was analysed by an Artificial Neural Network (ANN) approach using LVI to supervise the analysis. 89 transcripts were significantly associated (p < 0.001) with the presence of LVI. Calpastatin, a specific calpain inhibitor, had the second lowest selection error and was investigated in breast cancer specimens using real-time PCR (n = 56) and immunohistochemistry (n = 53). Both calpastatin mRNA and protein levels were significantly associated with the presence of LVI (p = 0.014 and p = 0.025 respectively). The data supports the hypothesis that calpastatin may play a role in regulating the initial metastatic dissemination of breast cancer. © 2011 Elsevier Ltd